Welcome to our dedicated page for High Templar news (Ticker: HTT), a resource for investors and traders seeking the latest updates and insights on High Templar stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect High Templar's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of High Templar's position in the market.
High Templar Tech (NYSE: HTT) reported unaudited results for Q4 and full year ended Dec 31, 2025. Q4 revenue was RMB3.2M and Q4 net loss was RMB163.1M (RMB1.03 per diluted ADS). FY2025 revenue fell 81.1% to RMB41.0M while FY net income was RMB708.6M (RMB4.25 per diluted ADS) driven by higher investment and derivative gains. Cash and equivalents totaled RMB5,532.4M with restricted cash RMB1,523.7M. The company continues transitioning away from last-mile delivery and executed share repurchases totaling ~182.3M ADSs through Mar 8, 2026.